Discover more insights into Pharmaceutical Firms 제약 회사

Keywords frequently search together with Pharmaceutical Firms 제약 회사

Narrow sentence examples with built-in keyword filters

Pharmaceutical Firms sentence examples within Indian Pharmaceutical Firms



ROLE OF INFORMATION AND PROMOTIONAL STRATEGIES FOR INDIAN PHARMACEUTICAL FIRMS IN THE AGE OF DIGITAL MARKETING


Innovation in Indian Pharmaceutical Industry: Impact of Changing Regulatory Regime

Pharmaceutical Firms sentence examples within Large Pharmaceutical Firms



Rushed Innovation: Evidence from Drug Licensing


Understanding the emergence of redistributed manufacturing: an ambidexterity perspective

Pharmaceutical Firms sentence examples within Major Pharmaceutical Firms



The Innovation-Remuneration Index (IRI). Making pharmaceutical companies report what matters about innovation.


A comprehensive insight on the COVID-19 vaccine candidates



Pharmaceutical Firms sentence examples within Listed Pharmaceutical Firms



Inventory conversion period and profitability relationship of the listed pharmaceutical firms of Jordan


The home country boundness of technological resources and internationalization performance

Pharmaceutical Firms sentence examples within Within Pharmaceutical Firms



Government Subsidy Strategy for Innovative Drug R&D Based on the Inter-Firm Spillovers


A qualitative approach to assess innovation in small infant industries within developing countries: The case of pharmaceuticals in Tunisia†

Pharmaceutical Firms sentence examples within U Pharmaceutical Firms



Product Complexity and Strategic Alliance on Drug Approval


Effects of CEO duality and tenure on innovation

Pharmaceutical Firms sentence examples within pharmaceutical firms operating



Moving Beyond the Valley of Death: Regulation and Venture Capital Investments in Early-Stage Biopharmaceutical Firms


An empirical investigation of innovation process in Indian pharmaceutical companies

Pharmaceutical Firms sentence examples within pharmaceutical firms listed



Determinants influencing liquidity of pharmaceutical firms listed on the Hanoi Stock Exchange


Effect of Working Capital Management of the Profitability of Listed Pharmaceutical Firms in Nigeria


“Qué Bonita Mi Tierra”



Drivers of Proactive Environmental Strategies: Evidence from the Pharmaceutical Industry of Asian Economies



Whither geographic proximity? Bypassing local R&D units in foreign university collaboration



When Do Firms Trade Patents?



TRANSFORMATIONAL STRATEGIES FOR OPTIMIZING USE OF MEDICATIONS AND RELATED THERAPIES THROUGH US PHARMACISTS AND PHARMACIES FROM 2021-2025: FINDINGS FROM A NATIONAL STUDY



COVID-19 vaccines: the dilemma when thinking as a patient



Determinants of radical drug innovation: a systematic literature review



Assessing the scale of adoption of sustainability practices by community pharmacies in Spain in the time of COVID-19



The effect of medical cannabis laws on pharmaceutical marketing to physicians.



The Health Impact Fund: making the case for engagement with pharmaceutical laboratories in Brazil, Russia, India, and China



Impact of Supply Chain Information Integration on Operational Performance of Pharmaceutical Firms: Mediating Role of Information Leakage



A beam search for the equality generalized symmetric traveling salesman problem



Generic Strategies and Performance of Pharmaceutical Manufacturing Companies in Nairobi County, Kenya



A Desk Top Allusion to The Rare Orphan Diseases and Orphan Drugs: Possessions to Discern by Every Healthcare Professional



Do Mandatory Disclosure Requirements for Private Firms Increase the Propensity of Going Public?



Pivotal Dose of Pembrolizumab: A Dose‐Finding Strategy for Immuno‐Oncology



Could Contracts between Pharmaceutical Firms and French Veterinarians Bias Prescription Behaviour: A Principal-Agency Theory Approach in the Context of Oligopolies



Does Employee Care Trigger Innovation Under a Healthy and Safe Working Environment? Evidence from the Pharmaceutical Industry in China



Effects of Reciprocity on Knowledge Sharing Behavior: The Mediating Role of Organizational Commitment



Drug Discovery Firms and Business Alliances for Sustainable Innovation



Divisive Faultlines and Knowledge Search in Technological Innovation Network: An Empirical Study of Global Biopharmaceutical Firms



Private and Social Returns to R&D: Drug Development and Demographics



The Role of Science in Drug Development Decisions



The Pharmaceutical Firms of Pakistan: An Overview of Multidimensional Performance



Public health insurance and pharmaceutical innovation: Evidence from China



Structural characteristics of extended alliance portfolio configuration and firm innovation



Inbound open innovation in biopharmaceutical firms: unpacking the role of absorptive capacity



Institutional investors and medical innovation



Did relaxing clinical trial regulation enhance the stock of scientific knowledge in India? Not necessarily



Factors influencing community pharmacists’ recommendation of over-the-counter medications in four Vietnam cities



Relationship between international experience and innovation performance: The importance of organizational learning for EMNEs



A research on effective management of manufacturing defects to avoid product recalls: A challenge to pharmaceutical industry



Inbound open innovation in biopharmaceutical firms: unpacking the role of absorptive capacity



A New Chapter



Review of Scientific Self-Experimentation: Ethics History, Regulation, Scenarios, and Views Among Ethics Committees and Prominent Scientists.



Iranian firms in biopharmaceutical value chain: where to go now?



Evaluation of the Effect of Financial Factors on Shareholders’ Value of Listed Pharmaceutical Firms in Nigeria



Business Model Design for Latecomers in Biopharmaceutical Industry: The Case of Korean Firms



Regulatory Review Time and Pharmaceutical R&D



The price of innovation - the role of drug pricing in financing pharmaceutical innovation. A conceptual framework



Behind the curtain



The Complexity of Pharmaceutical Prices: An Economic Analysis



Returns on different types of investment in the global pharmaceutical industry



Evaluation of stability using one versus three tubes for each quality control concentration in matrix-based bioanalysis.



Challenging the Problem of ‘Fit’: Advancing the Regenerative Medicine Industries in the United States, Britain and Japan


Learn more from Pharmaceutical Firms 제약 회사

Pharmaceutical Firms 제약 회사


Pharmaceutical Firms 제약 회사
Encyclopedia 백과사전